The National Oncologic PET Registry
Status unconfirmed
Conditions studied: Cancer
In brief
The Centers for Medicare \& Medicaid Services (CMS), as the Federal agency that administers the Medicare program, only pays for positron emission tomography (PET) scans in patients with cancer for certain reasons and for certain types of cancer. This study was developed to help CMS determine if they should pay for PET scans for additional reasons and additional types of cancer. In order to collect the information needed to decide which other types of cancer should be covered by Medicare, CMS will provide payment for the otherwise non-covered PET scans of patients who are properly registered with the National Oncologic PET Registry (NOPR). This information will then be analyzed to determine the effect PET scans had on the way physicians planned to treat their patients.
Key facts
- Study ID
- NCT00868582
- Run by
- American College of Radiology Imaging Network
- People needed
- 333000
- Starts
- 2006-05-01
- Expected to finish
- 2021-06-01
- Last updated by the study team
- 2020-08-25
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All Medicare beneficiaries who are referred for NaF-18 PET to identify bone metastasis are eligible to be included in the NOPR.
You may not qualify if…
- NaF-18 PET for other (non-oncologic) indications.
- NaF-18 PET performed as part of a clinical trial approved by CMS.
Where it is running
- American College of Radiology Imaging Network — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.